Article Information
History
- April 4, 2024.
Article Versions
- Version 1 (April 3, 2024 - 09:18).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- 1Department of Clinical Research and Epidemiology, the Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan
- 2Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan
- 3Division of Clinical Research, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan
- 4Department of Clinical Mycobacteriosis, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
- 5Department of Mycobacterium Reference and Research, the Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan
- 6Department of Basic Mycobacteriosis, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
- ↵†Corresponding author:
Yuko Hamaguchi, Department of Clinical Research and Epidemiology, the Research Institute of Tuberculosis, Japan, Anti-Tuberculosis Association, 3-1-24 Matsuyama, Kiyose, Tokyo 204-8522, Japan, TEL: +81 42 493 5798 (ext. 244), FAX: +8142 492 4600, Email: yh.ac.jp{at}gmail.com
↵* Equal contributions: the first two authors contributed equally to this paper.